BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
BEGIN:VEVENT
UID:26@myasthenia.org
DTSTART;TZID=America/New_York:20231025T220000
DTEND;TZID=America/New_York:20231026T000000
DTSTAMP:20241028T210312Z
URL:https://myasthenia.org/events/new-treatment-for-generalized-myasthenia
 -gravis-2023-10-25/
SUMMARY:New Treatment for Generalized Myasthenia Gravis
DESCRIPTION: New Treatment for Generalized Myasthenia Gravis Presented by:D
 r. Gil I. Wolfe\, MD\, FAAN  Irvin and Rosemary Smith Professor and Chairm
 an  SUNY Distinguished Professor  Dept. of Neurology\, Jacobs School of Me
 dicine and Biomedical Sciences  Univ. at Buffalo/SUNY   October 25\, 2023 
 @ 3PM Eastern\, 12PM Pacific Dr. Gil I. Wolfe\, MD\, FAAN will share educa
 tional information about a new targeted treatment for two subtypes of gene
 ralized myasthenia gravis (gMG). The webinar will include key details abou
 t the first FDA-approved treatment for both anti-AChR (acetylcholine recep
 tor) and anti-MuSK (muscle-specific tyrosine kinase) antibody-positive gMG
  in adults\, including how it works\, what patients and caregivers can exp
 ect with this treatment\, and helpful points for how to talk with a doctor
  about gMG symptoms and treatment. Sponsored by UCB.   Register for this w
 ebinar     
ATTACH;FMTTYPE=image/jpeg:https://myasthenia.org/wp-content/uploads/Portal
 s/0/EasyDNNNews/620/research-oct25-wolfe1-2.jpg
CATEGORIES:Events,Webinars
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
DTSTART:20230312T030000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR